Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Pneumonia Therapeutics Market
Pneumonia Therapeutics Market Size
- Report ID: GMI2029
- Published Date: Jun 2020
- Report Format: PDF
Pneumonia Therapeutics Market Size
Pneumonia Therapeutics Market size was USD 1.7 billion in 2019 and will grow at a CAGR of 7.6% from 2020 to 2026.
Pneumonia is widely referred to as a disease condition that affects the alveoli of the lungs. Pneumonia is caused by fungi, bacteria or viruses and accounts for 5% of deaths among children below 5 years of age. Prevalence of pneumonia is significantly high in paediatric population of African countries. However, lack of accessibility to pneumonia therapeutics and treatment facilities has kept mortality rate higher in African countries.
| Report Attribute | Details |
|---|---|
| Base Year: | 2019 |
| Pneumonia Therapeutics Market Size in 2019: | USD 1.68 Billion |
| Forecast Period: | 2020 to 2026 |
| Forecast Period 2020 to 2026 CAGR: | 7.6% |
| 2026 Value Projection: | USD 2.86 Billion |
| Historical Data for: | 2015 to 2019 |
| No. of Pages: | 180 |
| Tables, Charts & Figures: | 190 |
| Segments covered: | Drug Class, Age Group, Infection Type, Distribution Channel and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Pneumonia Therapeutics Market Scope
